Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Cutaneous Hypersensitivity Reaction After Phenytoin Therapy in a Neonate: A Case Report and Review of Literature Elucidating the Potential Pharmacological Plausibility and Preventive Strategies

Author(s): Praveenkumar Rajendran, Indumathi Prabath* and Jamuna Rani

Volume 18, Issue 4, 2023

Published on: 15 August, 2022

Page: [576 - 579] Pages: 4

DOI: 10.2174/1574886317666220531102026

Price: $65

Abstract

Background: Drug-induced hypersensitivity reaction is a potentially life-threatening condition reported among patients of different age groups. Phenytoin is a prototypic drug prescribed for the treatment of a variety of seizure disorders. Allergic reaction to phenytoin therapy in a newborn is relatively a rare clinical manifestation that is not frequently reported.

Objective: The objective of this study is to report a suspected case of hypersensitivity reaction in a newborn possibly due to phenytoin and the strategies to prevent these immune-mediated reactions.

Case Report: An early term newborn on the 4th day of life developed erythematous rashes over the abdominal region following phenytoin treatment for recurrent generalized tonic-clonic seizures. Prenatal history was uneventful except for the mother had preeclampsia during the third trimester of pregnancy. The suspected phenytoin was replaced with phenobarbitone to control seizure episodes. Subsequently, the rashes disappeared. The baby had also suffered from skin discolouration after phototherapy. Radiological investigations and cerebrospinal fluid culture were performed to detect the etiology of seizures.

Conclusion: Hypersensitivity reaction to phenytoin in newborns is a rare clinical entity but may lead to serious lethal complications. Thus, stringent clinical monitoring of patients on phenytoin therapy is mandatory, especially in the pediatric population.

Keywords: Hypersensitivity reactions, phenytoin, neonates, generalized tonic-clonic seizures, infant, phottotherapy.

« Previous Next »
[1]
Carder KR. Hypersensitivity reactions in neonates and infants. Dermatol Ther 2005; 18(2): 160-75.
[http://dx.doi.org/10.1111/j.1529-8019.2005.05014.x] [PMID: 15953145]
[2]
Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48(7): 1223-44.
[http://dx.doi.org/10.1111/j.1528-1167.2007.01041.x] [PMID: 17386054]
[3]
Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol 2012; 11(9): 792-802.
[http://dx.doi.org/10.1016/S1474-4422(12)70153-9] [PMID: 22832500]
[4]
Hebert AA, Ralston JP. Cutaneous reactions to anticonvulsant medications. J Clin Psychiatry 2001; 62 (Suppl. 14): 22-6.
[PMID: 11469671]
[5]
Mehta M, Shah J, Khakhkhar T, Shah R, Hemavathi KG. Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series. J Pharmacol Pharmacother 2014; 5(1): 59-62.
[http://dx.doi.org/10.4103/0976-500X.124428] [PMID: 24554914]
[6]
Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents--a 6 year series from Chandigarh, India. J Postgrad Med 2001; 47(2): 95-9.
[PMID: 11832597]
[7]
Geduk A, Birtas Atesoglu E, Mehtap O, et al. Late-onset anticonvulsant hypersensitivity syndrome mimicking lymphoma. Intern Med 2015; 54(24): 3201-4.
[http://dx.doi.org/10.2169/internalmedicine.54.5111] [PMID: 26666613]
[8]
Chadwick D, Shaw MD, Foy P, Rawlins MD, Turnbull DM. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry 1984; 47(6): 642-4.
[http://dx.doi.org/10.1136/jnnp.47.6.642] [PMID: 6234378]
[9]
Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64(7): 1134-8.
[http://dx.doi.org/10.1212/01.WNL.0000156354.20227.F0] [PMID: 15824335]
[10]
Gilliam F, Carter J, Vahle V. Tolerability of antiseizure medications: Implications for health outcomes. Neurology 2004; 63(10, Supplement 4) (Suppl. 4): S9-S12.
[http://dx.doi.org/10.1212/WNL.63.10_suppl_4.S9] [PMID: 15557551]
[11]
Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001; 108(2): 485-92.
[http://dx.doi.org/10.1542/peds.108.2.485] [PMID: 11483822]
[12]
Cumbo-Nacheli G, Weinberger J, Alkhalil M, Thati N, Baptist AP. Anticonvulsant hypersensitivity syndrome: Is there a role for immunomodulation? Epilepsia 2008; 49(12): 2108-12.
[http://dx.doi.org/10.1111/j.1528-1167.2008.01720.x] [PMID: 18637830]
[13]
Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011; 77(23): 2025-33.
[http://dx.doi.org/10.1212/WNL.0b013e31823b478c] [PMID: 22116946]
[14]
Chaudhary N, Kabra M, Gulati S, Gupta YK, Pandey RM, Bhatia BD. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy. BMC Pediatr 2016; 16(1): 66.
[http://dx.doi.org/10.1186/s12887-016-0603-0] [PMID: 27179628]
[15]
Fohner AE, Rettie AE, Thai KK, et al. Associations of CYP2C9 and CYP2C19 pharmacogenetic variation with phenytoin-induced cutaneous adverse drug reactions. Clin Transl Sci 2020; 13(5): cts.12787.
[http://dx.doi.org/10.1111/cts.12787] [PMID: 32216088]
[16]
Zuniga R, Nguyen T. Skin conditions: Common skin rashes in infants. FP Essent 2013; 407: 31-41.
[PMID: 23600337]
[17]
Kutlubay Z, Tanakol A, Engýn B, et al. Newborn skin: Common skin problems. Maedica 2017; 12(1): 42-7.
[PMID: 28878836]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy